Amgen Inc.�"s bone-strengthening drug denosumab, the focus of the largest development program in the company�"s history, was cleared by U.S. regulators for use in postmenopausal women with osteoporosis....
Read More...
[Source: BusinessWeek.com -- ]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment